Combination Therapy With Isotretinoin and Tamoxifen Expected to Provide Complete Protection Against Severe Acute Respiratory Syndrome Coronavirus
Clinical trial NCT04389580 · UNKNOWN
Trial details
- NCT number
- NCT04389580
- Sponsor
- Kafrelsheikh University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-01
- Primary completion
- 2021-10-01
- Enrollment
- 160
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.